P27 expression in epithelial ovarian tumors

International Journal of Gynecology and Obstetrics

Volumn 85, Issue 2, 2004, Pages 179-180

  Patah, L E M ^a,b   Camarotto, K C ^a   Goncalves W J ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Benign neoplasm of the ovary; Immunohistochemical; Ovarian cancer; Protein p27; Tumor of low malignant potential

Indexed keywords

PROTEIN P27;

ARTICLE; BENIGN TUMOR; CANCER GRADING; CANCER STAGING; CELL COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM TUMOR; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY ADENOCARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 1942488247     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2003.11.004     Document Type: Article

References (4)

1. Baekelandt M., Holm R., Trope C.G., Nesland J.M., Krinsten G.B. Lack of indepent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical study. Clin Cancer Res. 5:1999;2848-2853.
2. 27kip1 is a new prognostic marker associated with survival in epithelial ovarian tumors. Am J Pathol. 154:(1):1999;119-125.
3. Masciullo V., Sgambato A., Pacilio C., Pucci B., Ferrandina G., Palazzo J., et al. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res. 59:1999;3790-3794.
4. 27kip1. Cancer Res. 57:1997;5441-5445.